Study to Assess the Efficacy and Safety of SKI3246 in Subjects With Non-Constipation Irritable Bowel Syndrome
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of different doses of
SKI3246 compared with placebo in the treatment of patients with irritable bowel syndrome with
non-constipation.